230 related articles for article (PubMed ID: 8996547)
1. Leukocyte alkaline phosphatase and serum alkaline phosphatase in patients with metastatic breast and colon cancer.
Walach N; Gur Y
Neoplasma; 1996; 43(5):297-300. PubMed ID: 8996547
[TBL] [Abstract][Full Text] [Related]
2. Plasma acid and alkaline phosphatase in patients with breast cancer.
Nguyen M; Bonneterre J; Hecquet B; Desoize B; Demaille A
Anticancer Res; 1991; 11(2):831-3. PubMed ID: 2064338
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte alkaline phosphatase and carcinoembryonic antigen in breast cancer patients. Influence of the treatment on the markers.
Walach N; Guterman A; Zaidman JL; Scharf S; Weinberger L; Kaufman S
Neoplasma; 1990; 37(6):627-30. PubMed ID: 2274082
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of bone and tumour markers in patients with malignant diseases.
Oremek GM; Weis A; Sapoutzis N; Sauer-Eppel H
Anticancer Res; 2003; 23(2A):987-90. PubMed ID: 12820336
[TBL] [Abstract][Full Text] [Related]
5. Metastatic workup of patients with prostate cancer employing alkaline phosphatase and skeletal alkaline phosphatase.
Wolff JM; Ittel TH; Borchers H; Boekels O; Jakse G
Anticancer Res; 1999; 19(4A):2653-5. PubMed ID: 10470213
[TBL] [Abstract][Full Text] [Related]
6. Predictive relevance of soluble CD44v6 serum levels for the responsiveness to second line hormone- or chemotherapy in patients with metastatic breast cancer.
Kopp R; Classen S; Wolf H; Gholam P; Possinger K; Wilmanns W
Anticancer Res; 2001; 21(4B):2995-3000. PubMed ID: 11712800
[TBL] [Abstract][Full Text] [Related]
7. Determination and biological relevance of serum cross-linked type I collagen N-telopeptide and bone-specific alkaline phosphatase in breast metastatic cancer.
Kanakis I; Nikolaou M; Pectasides D; Kiamouris C; Karamanos NK
J Pharm Biomed Anal; 2004 Mar; 34(4):827-32. PubMed ID: 15019061
[TBL] [Abstract][Full Text] [Related]
8. Isoenzymes of alkaline and acid phosphatases as bones metastasis marker in breast cancer patients.
Desoize B; Veiler V; Pourny C; Comoe L; Jardillier JC
Anticancer Res; 1989; 9(4):1105-9. PubMed ID: 2817792
[TBL] [Abstract][Full Text] [Related]
9. Serum gamma glutamyl-transferase is a sensitive but unspecific marker of metastatic renal cell carcinoma.
Simic T; Dragicevic D; Savic-Radojevic A; Cimbaljevic S; Tulic C; Mimic-Oka J
Int J Urol; 2007 Apr; 14(4):289-93. PubMed ID: 17470155
[TBL] [Abstract][Full Text] [Related]
10. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
Brown JE; Cook RJ; Major P; Lipton A; Saad F; Smith M; Lee KA; Zheng M; Hei YJ; Coleman RE
J Natl Cancer Inst; 2005 Jan; 97(1):59-69. PubMed ID: 15632381
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte alkaline phosphatase and carcinoembryonic antigen in metastatic colorectal cancer patients.
Walach N; Guterman A; Zaidman JL; Kaufman S; Weimberger L; Scharf S
Tumori; 1991 Apr; 77(2):164-6. PubMed ID: 2048230
[TBL] [Abstract][Full Text] [Related]
12. [General activity and isoenzymatic spectrum of alkaline phosphatase in the diagnosis of breast cancer metastases].
Pashintseva LP; Portnoĭ SM
Vestn Khir Im I I Grek; 1981 Jan; 126(1):62-6. PubMed ID: 7222422
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status].
Bensouda Y; André F; Boulet T; Al-Ghuzlan A; Conforti R; Troalen F; Bourgier C; Errihani H; Spielmann M; Delaloge S
Bull Cancer; 2009 Oct; 96(10):923-8. PubMed ID: 19696005
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of elevated serum alkaline phosphatase levels preoperatively in patients with carcinoma of the colon and rectum.
Tartter PI; Slater G; Papatestas AE; Aufses AH
Surg Gynecol Obstet; 1984 Jun; 158(6):569-71. PubMed ID: 6729678
[TBL] [Abstract][Full Text] [Related]
15. Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease.
Berruti A; Mosca A; Tucci M; Terrone C; Torta M; Tarabuzzi R; Russo L; Cracco C; Bollito E; Scarpa RM; Angeli A; Dogliotti L
Endocr Relat Cancer; 2005 Mar; 12(1):109-17. PubMed ID: 15788643
[TBL] [Abstract][Full Text] [Related]
16. Assessment of circulating Dickkopf-1 with a new two-site immunoassay in healthy subjects and women with breast cancer and bone metastases.
Voorzanger-Rousselot N; Journe F; Doriath V; Body JJ; Garnero P
Calcif Tissue Int; 2009 May; 84(5):348-54. PubMed ID: 19252761
[TBL] [Abstract][Full Text] [Related]
17. Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions.
Coskun U; Bukan N; Sancak B; Günel N; Ozenirler S; Unal A; Yucel A
Neoplasma; 2004; 51(3):209-13. PubMed ID: 15254675
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival.
Singhal H; Bautista DS; Tonkin KS; O'Malley FP; Tuck AB; Chambers AF; Harris JF
Clin Cancer Res; 1997 Apr; 3(4):605-11. PubMed ID: 9815727
[TBL] [Abstract][Full Text] [Related]
19. Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis.
Koizumi M; Takahashi S; Ogata E
Anticancer Res; 2003; 23(5b):4095-9. PubMed ID: 14666607
[TBL] [Abstract][Full Text] [Related]
20. Alkaline phosphatase isoenzymes in detection and follow up of breast cancer metastases.
Ritzke C; Stieber P; Untch M; Nagel D; Eiermann W; Fateh-Moghadam A
Anticancer Res; 1998; 18(2B):1243-9. PubMed ID: 9615795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
